(Q45172832)

10 December 2017

title

POSTN/TGFBI-associated stromal signature predicts poor prognosis in serous epithelial ovarian cancer (English)

1 reference

10 December 2017

1 reference

5

Jenny Lester

1 reference

10 December 2017

8

Marlena Fejzo

1 reference

10 December 2017

2

Judy Dering

1 reference

10 December 2017

Beth Y Karlan

1

1 reference

10 December 2017

Christine Walsh

3

1 reference

10 December 2017

Sandra Orsulic

4

1 reference

10 December 2017

Lee A Anderson

6

1 reference

10 December 2017

Charles L Ginther

7

1 reference

10 December 2017

Dennis Slamon

9

1 reference

10 December 2017

language of work or name

English

0 references

publication date

22 December 2013

1 reference

10 December 2017

1 reference

10 December 2017

volume

132

1 reference

10 December 2017

issue

2

1 reference

10 December 2017

page(s)

334-342

1 reference

Effect of Screening on Ovarian Cancer Mortality

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.021

7 January 2021

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.021

Incorporation of bevacizumab in the primary treatment of ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.021

Intraperitoneal cisplatin and paclitaxel in ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.021

Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.021

Integrated genomic analyses of ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.021

Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.021

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.021

Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.021

Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.021

Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.021

Periostin promotes invasion and anchorage-independent growth in the metastatic process of head and neck cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.021

Periostin promotes ovarian cancer angiogenesis and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.021

Periostin: a bridge between cancer stem cells and their metastatic niche

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.021

Estrogens and epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.021

Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.021

Ovarian cancer incidence trends in relation to changing patterns of menopausal hormone therapy use in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.021

Squamous-cell carcinomas of the lung: emerging biology, controversies, and the promise of targeted therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.021

Genomics and the continuum of cancer care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.021

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.021

Making personalized cancer medicine a reality: challenges and opportunities in the development of biomarkers and companion diagnostics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.021

Prediction of optimal versus suboptimal cytoreduction of advanced-stage serous ovarian cancer with the use of microarrays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.021

Prediction of chemotherapeutic response in ovarian cancer with DNA microarray expression profiling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.021

High-resolution mapping of genomic imbalance and identification of gene expression profiles associated with differential chemotherapy response in serous epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.021

Gene expression profiles associated with response to chemotherapy in epithelial ovarian cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.021

Unique gene expression profile based on pathologic response in epithelial ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.021

Molecular profiling of platinum resistant ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.021

Gene expression profiles predict early relapse in ovarian cancer after platinum-paclitaxel chemotherapy

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.021

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.021

inferred from DOI database lookup

7 January 2021

based on heuristic

Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.021

Gene expression signature with independent prognostic significance in epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.021

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.021

A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.021

Gene expression profile for predicting survival in advanced-stage serous ovarian cancer across two independent datasets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.021

A prognostic gene expression index in ovarian cancer - validation across different independent data sets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.021

Profiling studies in ovarian cancer: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.021

BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.021

Cancer treatment according to BRCA1 and BRCA2 mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.021

Gene expression in epithelial ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.021

Neutralizing monoclonal antibody to periostin inhibits ovarian tumor growth and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.021

Expression of Wilms tumor gene (WT1) in epithelial ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.021

Hormone response in ovarian cancer: time to reconsider as a clinical target?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.021

10.1016/J.YGYNO.2013.12.021

7 January 2021

Identifiers

DOI

1 reference

10 December 2017

1 reference